CGR11, a classical pathway-regulated secretory protein, has demonstrated prognostic significance in prostate cancer and osteosarcoma (Díaz de la Guardia-Bolívar et al., 2022; Wei et al., 2024). Here, CGREF1 is linked to prostate cancer.